Clayton Duncan
Directeur Général chez Pamlico BioPharma, Inc.
Provenance du réseau au premier degré de Clayton Duncan
Entité | Type d'entité | Industrie | |
---|---|---|---|
Otologic Pharmaceutics, Inc.
Otologic Pharmaceutics, Inc. Pharmaceuticals: MajorHealth Technology Otologic Pharmaceutics, Inc. develops treatment for acute hearing loss. Its product HPN1010 is an oral medication to treat acute hearing loss to reduce the development of permanent hearing disorders. The company was founded by Richard Kopke, Robert A. Floyd and Dave karlman and is headquartered in Oklahoma City, OK.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Pamlico BioPharma, Inc.
Pamlico BioPharma, Inc. BiotechnologyHealth Technology Pamlico BioPharma, Inc. provides antibody therapeutics services. It develops fully-human monoclonal antibody (hmAb) therapeutics for the rapid diagnosis and treatment of infectious diseases and cancer. The firms lead program is focused on severe pneumonia caused by streptococcus pneumoniae (SPN), and is in preclinical IND-directed activities for a mAb cocktail and a companion point-of-care (POC) diagnostic against three serotypes that account for over 40% of SPN infections. The company was founded on 18 December, 2014 and is headquartered in Oklahoma, OK.
3
| Holding Company | Biotechnology | 3 |
Accele Biopharma, Inc.
Accele Biopharma, Inc. Investment ManagersFinance Accele Biopharma, Inc. (Accele Biopharma) is a venture capital firm founded in 2011. The firm is headquartered in Oklahoma City, Oklahoma.
1
| Private Company | Investment Managers | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Clayton Duncan via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Purdue University | College/University | Graduate Degree Doctorate Degree | |
Oklahoma City University | College/University | Masters Business Admin | |
Tremeau Pharmaceuticals, Inc.
Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
WAVE LIFE SCIENCES LTD. | Biotechnology | Director/Board Member | |
Perseus Holdings USA LLC
Perseus Holdings USA LLC Electronics DistributorsDistribution Services Perseus Holdings USA LLC markets vaccine platform technology. The company is headquartered in Austin, TX. | Electronics Distributors | Director/Board Member | |
Exacis Biotherapeutics, Inc.
Exacis Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Part of Eterna Therapeutics, Inc., Exacis Biotherapeutics, Inc. is a development stage immuno-oncology company based in Cambridge, MA. Exacis uses its proprietary-based technologies to engineer next generation off-the-shelf NK and T cell therapies aimed at liquid and solid tumors. Exacis has an exclusive license to the Factor Bioscience technology for engineered NK and T cell products derived from iPSCs for use in oncology and holds all development and commercial rights for these investigational candidates. Exacis' approach avoids the use of DNA and viruses and instead uses a proprietary-based technology to generate iPSCs and to edit their genome to create stealthed, performance-enhanced allogeneic NK and T cell products, termed ExANK™, Exacar-NK™, and Exacar-T™ cells. The company was founded in 2020 by Gregory Fiore, Matthew Angel, James Pan. Gregory Fiore has been the CEO since 2020. Exacis Biotherapeutics was acquired by Eterna Therapeutics, Inc. on May 02, 2023 for $49 million. | Medical/Nursing Services | Chairman | |
Wave Life Sciences USA, Inc.
Wave Life Sciences USA, Inc. Electric UtilitiesUtilities Part of Wave Life Sciences Ltd., Wave Life Sciences USA, Inc. is a company that provides nucleic acid therapeutics. The company is based in Cambridge, MA. The company was founded in 2012 by Gregory L. Verdine, Takeshi Wada. The CEO is Paul B. Bolno. | Electric Utilities | Director/Board Member | |
TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | President | |
University of Oklahoma | College/University | Undergraduate Degree | |
Chorus Labs LLC
Chorus Labs LLC Packaged SoftwareTechnology Services Chorus Labs LLC operates as a software company that creates tools for the modern workplace. Its product Baton is a task and project management application, encouraging users to delegate everything by passing the baton. The company was founded by Justin Reid Briggs and Matthew Sartin in 2012 and is headquartered in Oklahoma City, OK. | Packaged Software | Founder | |
Prime Movers Lab LLC
Prime Movers Lab LLC Investment ManagersFinance Prime Movers Lab LLC (Prime Movers Lab) is a venture capital firm founded in 2018 by Dakin Sloss. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Private Equity Investor | |
Elevian, Inc.
Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Iridia, Inc.
Iridia, Inc. Miscellaneous Commercial ServicesCommercial Services Iridia, Inc. operates as a biotechnology company. It offers research and development services. The company was founded by James P. Linton in 2016 and is headquartered in Carlsbad, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Iviva Medical, Inc.
Iviva Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Iviva Medical, Inc. develops autologous tissue to serve kidney diseases. The company was founded by Harald C Ott and is headquartered in Beverly, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Deep Science Ventures Ltd.
Deep Science Ventures Ltd. Investment ManagersFinance Deep Science Ventures Ltd. (Deep Science Ventures) is a venture capital firm founded 2016 by Mark Hammond and Dominic Falcão. The firm is headquartered in Essex, United Kingdom. | Investment Managers | Private Equity Investor | |
Oklahoma Medical Research Foundation
Oklahoma Medical Research Foundation Investment Trusts/Mutual FundsMiscellaneous Oklahoma Medical Research Foundation provides investment advice. The company was founded in 1946 and is headquartered in Oklahoma City, OK. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
University of Kentucky | College/University | Graduate Degree | |
NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Chairman | |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Georgia | College/University | Doctorate Degree | |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Virginia | College/University | Doctorate Degree | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
MEDICINOVA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
AVANIR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
EPIRUS BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
UNC School of Medicine | College/University | Corporate Officer/Principal | |
CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Executive Officer | |
COLUCID PHARMACEUTICALS INC | Biotechnology | Director/Board Member | |
Brighton Biotech, Inc.
Brighton Biotech, Inc. BiotechnologyHealth Technology Brighton Biotech, Inc. provides medical research services. It specializes in acquiring and developing pharmaceutical and biotechnology products intended for the treatment and prevention of serious unmet medical needs. The company was founded in 2010 and is headquartered in New York, NY. | Biotechnology | Corporate Officer/Principal | |
University of California, Davis | College/University | Graduate Degree |
Statistiques
Internationale
Etats-Unis | 39 |
Canada | 4 |
Singapour | 2 |
Royaume-Uni | 2 |
Irlande | 2 |
Sectorielle
Health Technology | 27 |
Consumer Services | 9 |
Distribution Services | 3 |
Health Services | 3 |
Finance | 3 |
Opérationnelle
Director/Board Member | 23 |
Chief Tech/Sci/R&D Officer | 8 |
Independent Dir/Board Member | 7 |
Corporate Officer/Principal | 5 |
President | 5 |
Relations les plus connectées
Insiders | |
---|---|
Mark Corrigan | 29 |
Justin Briggs | 9 |
Richard E. Gammans | 8 |
Robert A. Floyd | 5 |
Richard Kopke | 1 |
Kelle Jones | 1 |
- Bourse
- Insiders
- Clayton Duncan
- Connexions Sociétés